2026 Biotimize - Powered by Sthorm. All rights reserved.
                   

Biotimize

News

News #Aside

#Aside

Aside
Other categories:
Bioprocess
CDMO
Institutional
Partners
Research
Bioprocess CDMO Research
30, Jan 2026
Além do Transacional: Por que Parcerias Colaborativas são o Futuro do Setor Biotecnológico na América Latina

BR O mercado farmacêutico global atingiu um ponto de inflexão. Se antes as CDMOs (Contract Development and Manufacturing Organizations) eram vistas apenas como uma alternativa para suprir picos de demanda ou reduzir custos fixos, hoje elas são o núcleo da estratégia de lançamento de novos produtos. Para ilustrar essa realidade, basta olharmos para os dados… Continue reading Além do Transacional: Por que Parcerias Colaborativas são o Futuro do Setor Biotecnológico na América Latina

Bioprocess CDMO Research
08, Dec 2025
The FDA Has Changed Key Requirements for Biosimilars: What This Means — and Why Now Is the Right Time to Start Development

BR O FDA introduziu mudanças relevantes em suas orientações para biossimilares, reforçando a possibilidade de que, em muitos casos, estudos clínicos comparativos de eficácia podem não ser mais necessários, desde que haja um pacote robusto de evidências analíticas, de farmacocinética (PK) e imunogenicidade. Essa atualização representa um movimento global de simplificação regulatória e traz impactos… Continue reading The FDA Has Changed Key Requirements for Biosimilars: What This Means — and Why Now Is the Right Time to Start Development

Bioprocess CDMO Institutional
28, Aug 2025
Biotimize: the bridge between translational science and biopharmaceutical self-sufficiency in Brazil

🇺🇸 In Brazil, the conversation about translational science has gained enormous relevance. The challenge of transforming scientific discoveries into therapies that truly reach patients requires more than research—it demands infrastructure, expertise, and the ability to scale innovation into real products. This is where Biotimize plays a unique and strategic role. As Brazil’s first Contract Development… Continue reading Biotimize: the bridge between translational science and biopharmaceutical self-sufficiency in Brazil

Bioprocess CDMO Institutional
04, Apr 2025
Biotimize’s Role in Building Biopharmaceutical Self-Sufficiency in Brazil

🇺🇸  The COVID-19 pandemic exposed a well-known truth within the healthcare sector: Brazil and Latin America are heavily dependent on international biopharmaceutical production. Whether due to technological limitations, lack of infrastructure, or a fragmented innovation ecosystem, the region still faces significant challenges in guaranteeing independent and sustainable access to advanced therapies. In this context, having… Continue reading Biotimize’s Role in Building Biopharmaceutical Self-Sufficiency in Brazil

LGPD

Rigorous company in relation to the general data protection law (LGPD)

Biotimize - Biotechnology as a Service is committed to complying with the laws that protect the privacy of the data of its employees, partners and the general public.
See how we deal with the information collected:

What are the data types? Personal data:
”Information related to the identified or viral person”, for example: first name, last name, date of birth, personal documents, home or business address, telephone, email and IP address.

Sensitive Personal data:
These are the data that refer to racial or ethnic origin, religious conviction, political opinion, union affiliation or organization of a religious, philosophical or political nature. Sensitive personal data as well are those related to health or sex life, genetic or biometric data.

What data does our Company collect? Our company handles data from employees, partners and service providers, being duly compliant with the LGPD.
On the website, the company collects data through the voluntary and consensual completion of forms, e-books and contact to receive the newsletter.

Is there automatic data collection? Biotimize - Biotechnology as a Service does not automatically collect data in each access to the website.

How do they use my data? The personal data provided by users who fill in the forms are used solely to provide feedback at the user's request (individual or legal entity interested in our company's products and services).
Once the service is completed, such data is deleted.

Have you got any questions? Talk to the Data Protection Manager (DPO) by email: dpo@biotimize.com.br
You will be able to clarify doubts related to the processing of personal data.